Related Experiment Videos
Telomeres and chromosome instability.
1Department of Radiation Oncology, University of California, San Francisco, 1855 Folsom Street, MCB 200, San Francisco, CA 94103, USA. murnane@rorl.ucsf.edu
DNA Repair
|June 21, 2006
Summary
Telomere loss in cancer cells can lead to chromosome instability through breakage/fusion/bridge cycles. This process generates genetic alterations and amplifies DNA, contributing to cancer evolution and karyotypic changes.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- Genomic instability accelerates cancer cell evolution by accumulating genetic changes.
- Telomeres, protective DNA-protein complexes at chromosome ends, prevent fusion.
- Telomere loss is a mechanism for chromosome instability, occurring spontaneously in cancer cells.
Purpose of the Study:
- To investigate the consequences of telomere loss in mouse embryonic stem cells and human tumor cell lines.
- To understand how telomere loss contributes to genomic alterations associated with cancer.
Main Methods:
- Utilized cell lines (mouse embryonic stem cells, human tumor lines) with selectable marker genes adjacent to telomeres.
- Observed and analyzed cellular responses following induced or spontaneous telomere loss.
Main Results:
- Telomere loss triggers either new telomere addition or sister chromatid fusion, leading to breakage/fusion/bridge (B/F/B) cycles.
- B/F/B cycles result in DNA amplification, large terminal deletions, and transfer of amplified regions to other chromosomes via double-minute chromosomes or end-to-end fusions.
- Chromosomes acquire new telomeres through translocations, which can be nonreciprocal (destabilizing the donor) or duplicative (causing allelic imbalance).
Conclusions:
- Single telomere loss can induce diverse chromosome alterations common in human cancers.
- These alterations affect both the initially affected chromosome and others.
- Factors promoting spontaneous telomere loss and B/F/B cycles are critical in generating cancer-associated karyotypic changes.